APRE
Aprea Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.29 / 10Overall Score
NeturalInvestment Rating
4.29 / 10Overall Score
NeturalInvestment Rating
Should I Buy APRE Now?
- Based on a composite score of 4.29/10, we rate APRE as a Netural. Our analysis breaks down into 3.44/10 for Fundamentals, 3.41/10 for Technicals, and 5.14/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for APRE?
Is APRE fundamentally strong?
What is the market sentiment for APRE?
Should I Buy APRE Now?
- Based on a composite score of 4.29/10, we rate APRE as a Netural. Our analysis breaks down into 3.44/10 for Fundamentals, 3.41/10 for Technicals, and 5.14/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is APRE fundamentally strong?
What is the current technical signals for APRE?
What is the market sentiment for APRE?
